Febo G 80mg Tablet, containing Febuxostat, is a potent xanthine oxidase inhibitor designed for managing hyperuricemia and gout. This prescription medication effectively reduces uric acid levels in the blood, preventing painful gout attacks and kidney complications.

Uses

Febo G 80mg Tablet primarily treats chronic hyperuricemia in conditions like gout. It’s particularly effective for patients who can’t tolerate allopurinol or have kidney impairment. The medication prevents gout flares by consistently maintaining lower uric acid levels.

Benefits

• Effectively lowers elevated uric acid levels
• Prevents acute gout attacks
• Reduces risk of kidney complications
• Better tolerability than alternative treatments
• Suitable for patients with kidney impairment
• Does not require dose adjustment in mild liver disease
• Shows consistent therapeutic response
• Provides once-daily dosing convenience
• Reduces tophi formation
• Minimizes joint damage from chronic gout

How It Works

Febo G 80mg works by inhibiting xanthine oxidase, the enzyme responsible for uric acid production. This mechanism effectively reduces uric acid formation and helps dissolve existing uric acid crystals in joints, preventing gout attacks and tissue damage.

Duration of Action

Initial uric acid reduction occurs within 24-48 hours of starting Febo G therapy. Maximum effectiveness is typically achieved within 2-4 weeks. The medication maintains consistent uric acid control with regular once-daily dosing.

Dosage

Standard dose: One Febo G 80mg tablet once daily Starting dose may be lower (40mg) for some patients Take with or without food at the same time each day Duration of treatment determined by healthcare provider

Side Effects

Common reactions include mild liver enzyme elevations, nausea, and joint pain. Some patients may experience headache or skin rash. Monitor for signs of liver problems or severe skin reactions.

Warning

Regular liver function monitoring is essential while taking Febo G 80mg. Discontinue if severe skin reactions or signs of liver damage occur. May increase risk of cardiovascular events in patients with existing heart disease.

Pregnancy and Breastfeeding

Not recommended during pregnancy due to limited safety data. Breastfeeding mothers should avoid Febo G 80mg as effects on nursing infants are unknown.

Interactions

• May interact with certain cancer treatments
• Use caution with azathioprine
• Potential interaction with theophylline
• Avoid mercaptopurine combination
• Monitor when used with NSAIDs

Important Information

Store Febo G 80mg Tablets at room temperature. Continue taking even after feeling better. Initial gout flares may occur when starting treatment. Maintain adequate hydration and follow dietary restrictions. Regular monitoring of uric acid levels and liver function is essential.